Brief: InSilico Medicine Cayman TopCo Posts HY Profit Of US$35.5 MLN
BRIEF-InSilico Medicine Cayman TopCo Posts HY Profit Of US$35.5 MLN Aug 26 (Reuters) - INSILICO Medicine Cayman TopCo HY profit US$35.5 MLN.
- InSilico Medicine Cayman TopCo HY Revenue US$106.3 MLN
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7